As we have shown that IL-13 can upregulate Matrix metalloproteinases (MMPs) expression in IL-13Rα2 expressing pancreatic cancer cell lines [28], we investigated the impact of IL-13Rα2 upregulation by HDAC inhibitors by examining IL-13 induced MMPs expression. Here, HDAC9 is linked to familial pancreatic carcinoma.